NextCure
NXTC
52 hedge funds and large institutions have $348M invested in NextCure in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 5 closing their positions.
234% more capital inflows, than outflows
Capital inflows: $63.3M | Capital outflows: $19M
180% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 5
18% more funds holding
Funds holding: 44 → 52 (+8)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
2.23% more ownership
Funds ownership: 47.45% → 49.69% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$26.5M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$13.5M |
| 3 |
EcoR1 Capital
San Francisco,
California
|
+$6.79M |
| 4 |
BlackRock
New York
|
+$2.82M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.13M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.48M |
| 3 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.13M |
| 4 |
Fosun International
Hong Kong,
China
|
-$2.25M |
| 5 |
DAFNA Capital Management
Los Angeles,
California
|
-$1.44M |
NXTC Hedge Fund Activity: Q3 2019 in Review
52 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2019, worth a combined $348M — up 116% from $161M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new NXTC positions and 5 closed out — a net gain of 9 holders — while 16 added to existing stakes and 14 trimmed.
The largest buyer was HHLR Advisors, adding an estimated $26.5M. The largest seller was Citadel Advisors, cutting an estimated $4.13M.
- 52 institutional investors held NextCure (NXTC) as of Q3 2019, up from 44 in Q2 2019.
- Funds reported $348M of NextCure stock for Q3 2019, up 116% quarter-over-quarter.
- 14 funds opened new NextCure positions in Q3 2019 and 5 closed out, a net change of +9 holders.
- The largest NextCure buyer in Q3 2019 was HHLR Advisors, an estimated $26.5M added.
- The largest NextCure seller in Q3 2019 was Citadel Advisors, an estimated $4.13M sold.
Based on aggregated 13F filings for Q3 2019.